Black Rock Inc. Myriad Genetics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Black Rock Inc. holds 15,150,806 shares of MYGN stock, worth $157 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,150,806
Previous 14,879,319
1.82%
Holding current value
$157 Million
Previous $317 Million
16.82%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding MYGN
# of Institutions
228Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Vanguard Group Inc Valley Forge, PA10.6MShares$110 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$62.1 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$57.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$44.9 Million0.03% of portfolio
-
Glenview Capital Management, LLC New York, NY4.16MShares$43 Million1.44% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $834M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...